Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Nalidixic acid
Drug ID BADD_D01521
Description Nalidixic acid is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA gyrase.
Indications and Usage For the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of E. Coli, Enterobacter species, Klebsiella species, and Proteus species.
Marketing Status Discontinued
ATC Code J01MB02
DrugBank ID DB00779
KEGG ID D00183
MeSH ID D009268
PubChem ID 4421
TTD Drug ID D07JGT
NDC Product Code Not Available
Synonyms Nalidixic Acid | Acid, Nalidixic | Nalidixin | Nalidixate Sodium Anhydrous | Anhydrous, Nalidixate Sodium | Sodium Anhydrous, Nalidixate | Sodium Nalidixic Acid, Anhydrous | Nevigramon | Nalidixate Sodium | Sodium, Nalidixate | Sodium Nalidixic Acid, Monohydrate
Chemical Information
Molecular Formula C12H12N2O3
CAS Registry Number 389-08-2
SMILES CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Arthralgia15.01.02.001--
Asthenia08.01.01.001--Not Available
Blister23.03.01.001; 12.01.06.002--Not Available
Cholestasis09.01.01.001--Not Available
Colour blindness acquired06.02.09.002--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis bullous23.03.01.002--
Diarrhoea07.02.01.001--
Diplopia17.17.01.005; 06.02.06.002--Not Available
Disturbance in attention19.21.02.002; 17.03.03.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Eosinophilia01.02.04.001--
Epilepsy17.12.03.002--Not Available
Erythema23.03.06.001--Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Fontanelle bulging18.04.04.001; 17.02.05.006--Not Available
Gastrointestinal pain07.01.05.005--
Glucose-6-phosphate dehydrogenase deficiency14.14.03.001; 03.08.03.001; 01.06.05.001--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Headache17.14.01.001--
Injury12.01.08.004--Not Available
Intracranial pressure increased17.07.02.002--Not Available
Joint stiffness15.01.02.003--Not Available
Leukopenia01.02.02.001--Not Available
Metabolic acidosis14.01.01.003--Not Available
Nausea07.01.07.001--
The 1th Page    1 2    Next   Last    Total 2 Pages